Abdominal and pelvic 18F-FDG PET/MR: a review of current and emerging oncologic applications

Ryan D. Ward; Barbara Amorim; Weier Li; Joseph King; Lale Umutlu; David Groshar; Mukesh Harisinghani; Onofrio Catalano

doi:10.1007/s00261-020-02766-2

Abdominal and pelvic ¹⁸F-FDG PET/MR: a review of current and emerging oncologic applications

Ryan D. Ward, Barbara Amorim, Weier Li, Joseph King, Lale Umutlu, David Groshar, Mukesh Harisinghani, Onofrio Catalano^*

^*Corresponding author for this work

Diagnostic Imaging

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Positron emission tomography (PET) using fluorodeoxyglucose (¹⁸F-FDG) combined with magnetic resonance imaging (MR) is an emerging hybrid modality that has shown utility in evaluating abdominal and pelvic disease entities. Together, the high soft tissue contrast and metabolic/functional imaging capabilities make this modality ideal for oncologic imaging in many organ systems. Its clinical utility continues to evolve and future research will help solidify its role in oncologic imaging. In this manuscript, we aim to (1) provide an overview of the various PET/MR systems, describing the strengths and weaknesses of each system, and (2) review the oncologic applications for ¹⁸F-FDG PET/MR in the abdomen and pelvis.

Original language	English
Pages (from-to)	1236-1248
Number of pages	13
Journal	Abdominal Radiology
Volume	46
Issue number	3
DOIs	https://doi.org/10.1007/s00261-020-02766-2
State	Published - Mar 2021

Keywords

Cancer
Oncology
PET/MR
PET/MRI
Staging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00261-020-02766-2

Cite this

@article{ed73b4ebf7f24811859a58cb68562a74,

title = "Abdominal and pelvic 18F-FDG PET/MR: a review of current and emerging oncologic applications",

abstract = "Positron emission tomography (PET) using fluorodeoxyglucose (18F-FDG) combined with magnetic resonance imaging (MR) is an emerging hybrid modality that has shown utility in evaluating abdominal and pelvic disease entities. Together, the high soft tissue contrast and metabolic/functional imaging capabilities make this modality ideal for oncologic imaging in many organ systems. Its clinical utility continues to evolve and future research will help solidify its role in oncologic imaging. In this manuscript, we aim to (1) provide an overview of the various PET/MR systems, describing the strengths and weaknesses of each system, and (2) review the oncologic applications for 18F-FDG PET/MR in the abdomen and pelvis.",

keywords = "Cancer, Oncology, PET/MR, PET/MRI, Staging",

author = "Ward, {Ryan D.} and Barbara Amorim and Weier Li and Joseph King and Lale Umutlu and David Groshar and Mukesh Harisinghani and Onofrio Catalano",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2021",

month = mar,

doi = "10.1007/s00261-020-02766-2",

language = "אנגלית",

volume = "46",

pages = "1236--1248",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - Abdominal and pelvic 18F-FDG PET/MR

T2 - a review of current and emerging oncologic applications

AU - Ward, Ryan D.

AU - Amorim, Barbara

AU - Li, Weier

AU - King, Joseph

AU - Umutlu, Lale

AU - Groshar, David

AU - Harisinghani, Mukesh

AU - Catalano, Onofrio

PY - 2021/3

Y1 - 2021/3

N2 - Positron emission tomography (PET) using fluorodeoxyglucose (18F-FDG) combined with magnetic resonance imaging (MR) is an emerging hybrid modality that has shown utility in evaluating abdominal and pelvic disease entities. Together, the high soft tissue contrast and metabolic/functional imaging capabilities make this modality ideal for oncologic imaging in many organ systems. Its clinical utility continues to evolve and future research will help solidify its role in oncologic imaging. In this manuscript, we aim to (1) provide an overview of the various PET/MR systems, describing the strengths and weaknesses of each system, and (2) review the oncologic applications for 18F-FDG PET/MR in the abdomen and pelvis.

AB - Positron emission tomography (PET) using fluorodeoxyglucose (18F-FDG) combined with magnetic resonance imaging (MR) is an emerging hybrid modality that has shown utility in evaluating abdominal and pelvic disease entities. Together, the high soft tissue contrast and metabolic/functional imaging capabilities make this modality ideal for oncologic imaging in many organ systems. Its clinical utility continues to evolve and future research will help solidify its role in oncologic imaging. In this manuscript, we aim to (1) provide an overview of the various PET/MR systems, describing the strengths and weaknesses of each system, and (2) review the oncologic applications for 18F-FDG PET/MR in the abdomen and pelvis.

KW - Cancer

KW - Oncology

KW - PET/MR

KW - PET/MRI

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=85091146660&partnerID=8YFLogxK

U2 - 10.1007/s00261-020-02766-2

DO - 10.1007/s00261-020-02766-2

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 32949272

AN - SCOPUS:85091146660

SN - 2366-004X

VL - 46

SP - 1236

EP - 1248

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 3

ER -